374 related articles for article (PubMed ID: 12136359)
1. Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.
Adachi M; Kurimura M; Saito S; Hosoya T; Kayama T; Kato T
Neuroradiology; 2002 Jul; 44(7):579-85. PubMed ID: 12136359
[TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
Moriwaka F; Tashiro K; Itoh K; Hamada T; Miyasaka K
Rinsho Shinkeigaku; 1992 Jan; 32(1):8-12. PubMed ID: 1628441
[TBL] [Abstract][Full Text] [Related]
3. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
6. Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy.
Jahanshahi M; Rowe J; Saleem T; Brown RG; Limousin-Dowsey P; Rothwell JC; Thomas DG; Quinn NP
J Cogn Neurosci; 2002 Feb; 14(2):298-310. PubMed ID: 11970793
[TBL] [Abstract][Full Text] [Related]
7. [MRI in Parkinson's disease and vascular parkinsonism--study on the lesion of substantia nigra].
Aotsuka A; Shinotoh H; Hirayama K; Ikehira H; Fukuda H
Rinsho Shinkeigaku; 1991 Jun; 31(6):619-24. PubMed ID: 1934776
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
9. Structural changes in the midbrain with aging and Parkinson's disease: an MRI study.
Sohmiya M; Tanaka M; Aihara Y; Okamoto K
Neurobiol Aging; 2004 Apr; 25(4):449-53. PubMed ID: 15013565
[TBL] [Abstract][Full Text] [Related]
10. [Stereotactic microelectrode-guided posteroventral pallidotomy for Parkinson's disease].
Huang YA; Yin Z; Zhang BG; Cheng GG; Wu C; Ma HW; Xiao CZ; Wang XK
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):106-8. PubMed ID: 12783670
[TBL] [Abstract][Full Text] [Related]
11. [Microelectrode-guided posteroventral medial pallidotomy for Parkinson's disease].
Xu R; Zhang W; Zhang S; Li Y; Yang Z; Huang R; Ye Y
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):485-7, 35. PubMed ID: 11829895
[TBL] [Abstract][Full Text] [Related]
12. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
13. Combined stereotactic thalamotomy and posteroventral pallidotomy for Parkinson's disease.
Iacono RP; Henderson JM; Lonser RR
J Image Guid Surg; 1995; 1(3):133-40. PubMed ID: 9079438
[TBL] [Abstract][Full Text] [Related]
14. [Importance of magnetic resonance in Parkinson disease. An analytic study of the pars compacta].
Maurício JC; Coelho H; Sá J; Martins A
Acta Med Port; 1990; 3(2):85-8. PubMed ID: 2349893
[TBL] [Abstract][Full Text] [Related]
15. [High field magnetic resonance imaging in Wilson's disease].
Hitoshi S; Nangaku M; Shimada H; Yamada H; Yoshikawa H; Iwata M
Rinsho Shinkeigaku; 1990 Feb; 30(2):139-45. PubMed ID: 2350924
[TBL] [Abstract][Full Text] [Related]
16. Health related quality of life in patients with Parkinson's disease two years following posteroventral pallidotomy.
Zimmerman GJ; D'Antonio LL; Iacono RP
Acta Neurochir (Wien); 2004 Dec; 146(12):1293-9; discussion 1299. PubMed ID: 15565472
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging.
Adachi M; Hosoya T; Haku T; Yamaguchi K; Kawanami T
AJNR Am J Neuroradiol; 1999 Sep; 20(8):1500-6. PubMed ID: 10512237
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of the midbrain in Parkinson's disease.
Duguid JR; De La Paz R; DeGroot J
Ann Neurol; 1986 Dec; 20(6):744-7. PubMed ID: 3813504
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and MRI correlation in multiple system atrophy].
Negoro K; Morimatsu M
No To Shinkei; 1994 May; 46(5):473-8. PubMed ID: 8060686
[TBL] [Abstract][Full Text] [Related]
20. [The role of magnetic resonance imaging in the diagnosis of Hallervorden-Spatz disease].
Tabuchi M; Mori E; Yamadori A
Rinsho Shinkeigaku; 1990 Sep; 30(9):972-7. PubMed ID: 2265508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
